Effect of infusion of a triacylglycerol emulsion on low-density lipoprotein composition and oxidizability

Atherosclerosis

Volumn 137, Issue 1, 1998, Pages 115-123

  Callow, Joanne ^a   Samra, Jaswinder S ^a   Frayn, Keith N ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Acute hypertriglyceridaemia; Intralipid; Lipid oxidation; Low density lipoprotein; Triacylglycerol

Indexed keywords

INTRALIPID; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; HUMAN; HUMAN EXPERIMENT; HYPERTRIGLYCERIDEMIA; LIPID OXIDATION; LIPOPROTEIN BLOOD LEVEL; MALE; NORMAL HUMAN; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0032478231     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(97)00261-X     Document Type: Article

References (39)

1. Patsch JR, Miesenböck G, Hopferwieser T, Mühlberger V, Knapp E, Dunn JK, Gotto AMJ, Patsch W Relation of triglyceride metabolism and coronary artery disease: studies in the postprandial state. Arterioscler Thromb. 12:1992;1336-1345.
2. Nikkila M, Solakivi T, Lehtimaki T, Koivula T, Laippala P, Astrom B Post-prandial plasma lipoprotein changes in relation to apolipoprotein E phenotypes and low density lipoprotein size in men with and without coronary artery disease. Atherosclerosis. 106:1994;149-157.
3. Karpe F, Hamsten A Postprandial lipoprotein metabolism and atherosclerosis. Curr Opin Lipidol. 6:1995;123-129.
4. Krauss RM, Burke DJ Identification of multiple subclasses of plasma low density lipoproteins in normal humans. J Lipid Res. 23:1982;97-104.
5. Dormans TPJ, Swinkels DW, de Graaf J, Hendriks JCM, Stalenhoef AFH, Demacker PNM Single-spin density gradient ultracentrifugation versus gradient gel electrophoresis: two methods for detecting low-density lipoprotein heterogeneity compared. Clin Chem. 37:1991;853-858.
6. Austin MA Triacylglycerol and coronary heart disease. Proc Nutr Soc. 56:1997;667-670.
7. Austin MA, King M-C, Vranizan KM, Krauss RM Atherogenic lipoprotein phenotype: a proposed genetic marker for coronary heart disease risk. Circulation. 82:1990;495-506.
8. Larsen ML, Illingworth DR Triglyceride-lowering agents: fibrates and nicotinic acid. Curr Opin Lipidol. 4:1993;34-40.
9. de Graaf J, Hendriks JCM, Demacker PNM, Stalenhoef AFH Identification of multiple dense LDL subfractions with enhanced susceptibility to in vitro oxidation among hypertriglyceridemic subjects: normalization after clofibrate treatment. Arterioscler Thromb. 13:1993;712-719.
10. Williams PT, Krauss RM, Vranizan KM, Wood PDS Changes in lipoprotein subfractions during diet-induced and exercise-induced weight loss in moderately overweight men. Circulation. 81:1990;1293-1304.
11. de Graaf J, Hak-Lemmers HLM, Hectors MPC, Demacker PNM, Hendriks JCM, Stalenhoef AFH Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects. Arterioscler Thromb. 11:1991;298-306.
12. Dejager S, Bruckert E, Chapman MJ Dense low density lipoprotein subspecies with diminished oxidative resistance predominate in combined hyperlipidemia. J Lipid Res. 34:1993;295-308.
13. Steinberg D Lipoprotein modification and atherogenesis. Atherosclerosis Rev. 23:1991;115-121.
14. Palinski W, Rosenfeld ME, Ylä-Herttuala S, Gurtner GC, Socher SS, Butler SW, Parthasarathy S, Carew TE, Steinberg D, Witztum JL Low density lipoprotein undergoes oxidative modification in vivo. Proc Nat Acad Sci USA. 86:1989;1372-1376.
15. Miesenböck G, Patsch JR Postprandial hyperlipidemia: the search for the atherogenic lipoprotein. Curr Opin Lipidol. 3:1992;196-201.
16. Mann CJ, Yen FT, Grant AM, Bihain BE Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia. J Clin Invest. 88:1991;2059-2066.
17. Granot E, Deckelbaum RJ, Eisenberg S, Oschry Y, Bengtsson-Olivecrona G Core modification of human low-density lipoprotein by artificial triacylglycerol emulsion. Biochim Biophys Acta. 833:1985;308-315.
18. Galeano NF, Milne R, Marcel YL, Walsh MT, Levy E, Ngu'yen T-D, Gleeson A, Arad Y, Witte L, Al-Haideri M, Rumsey SC, Deckelbaum RJ Apoprotein B structure and receptor recognition of triglyceride-rich low density lipoprotein (LDL) is modified in small LDL but not in triglyceride-rich LDL of normal size. J Biol Chem. 269:1994;511-519.
19. Attia N, Durlach V, Paul JL, Soni T, Betoulle D, Girard-Globa A Modulation of low density lipoprotein subclasses by alimentary lipaemia in control and normotriglyceridemic non-insulin-dependent diabetic subjects. Atherosclerosis. 113:1995;197-209.
20. Lechleitner M, Hopplicher F, Föger B, Patsch JR Low-density lipoproteins of the postprandial state induce cellular cholesteryl ester accumulation in macrophages. Arterioscler Thromb. 14:1994;1799-1807.
21. Potts JL, Fisher RM, Humphreys SM, Coppack SW, Gibbons GF, Frayn KN Peripheral triacylglycerol extraction in the fasting and post-prandial states. Clin Sci. 81:1991;621-626.
22. Griffin BA, Caslake MJ, Yip B, Tait GW, Packard CJ, Shepherd J Rapid isolation of low density lipoprotein (LDL) subfractions from plasma by density gradient ultracentrifugation. Atherosclerosis. 83:1990;59-67.
23. Holmquist L Surface modification of Beckman Ultra-Clear centrifuge tubes for density gradient centrifugation of lipoproteins. J Lipid Res. 23:1982;1249-1250.
24. Humphreys SM, Fisher RM, Frayn KN Micro-method for measurement of sub-nanomole amounts of triacylglycerol. Ann Clin Biochem. 27:1990;597-598.
25. Esterbauer H, Striegl G, Puhl H, Rotheneder M Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Rad Res Commun. 6:1989;67-75.
26. El-Saadani M, Esterbauer H, El-Sayed M, Goher M, Nassar AY, Jürgens G A spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent. J Lipid Res. 30:1989;627-630.
27. Schaefer EJ, Eisenberg S, Levy RI Lipoprotein apoprotein metabolism. J Lipid Res. 19:1978;667-687.
28. Berliner JA, Haberland ME The role of oxidized low-density lipoprotein in atherogenesis. Curr Opin Lipidol. 4:1993;373-381.
29. Reaven PD, Grasse BJ, Tribble DL Effects of linoleate-enriched and oleate-enriched diets in combination with α-tocopherol on the susceptibility of LDL and LDL subfractions to oxidative modification in humans. Arterioscler Thromb. 14:1994;557-566.
30. Thomas MJ, Thornburg T, Manning J, Hooper K, Rudel LL Fatty acid composition of low-density lipoprotein influences its susceptibility to autoxidation. Biochemistry. 33:1994;1828-1834.
31. Bonanome A, Pagnan A, Biffanti S, Opportuno A, Sorgato F, Dorella M, Maiorino M, Ursini F Effect of dietary monounsaturated and polyunsaturated fatty acids on the susceptibility of plasma low density lipoproteins to oxidative modification. Arterioscler Thromb. 12:1992;529-533.
32. Tribble DL, Holl LG, Wood PD, Krauss RM Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size. Atherosclerosis. 93:1992;189-199.
33. Thomas SR, Neuzil J, Mohr D, Stocker R Coantioxidants make α-tocopherol an efficient antioxidant for low-density lipoprotein. Am J Clin Nutr. 62:1995;1357S-1364S.
34. Esterbauer H, Puhl H, Dieber-Rotheneder M, Waeg G, Rabl H Effect of antioxidants on oxidative modification of LDL. Ann Med. 23:1991;573-581.
35. Massey JB Kinetics of transfer of α-tocopherol between model and native plasma lipoproteins. Biochim Biophys Acta. 793:1984;387-392.
36. Traber MG, Carpentier YA, Kayden HJ, Richelle M, Galeano NF, Deckelbaum RJ Alterations in plasma α- and γ-tocopherol concentrations in response to intravenous infusion of lipid emulsions in humans. Metabolism. 42:1993;701-709.
37. Griffin E, Breckenridge WC, Kuksis A, Bryan MH, Angel A Appearance and characterization of lipoprotein X during continuous Intralipid infusions in the neonate. J Clin Invest. 64:1979;1703-1712.
38. Hajri T, Férézou J, Lutton C Effects of intravenous infusions of commercial fat emulsions (Intralipid 10 or 20%) on rat plasma lipoproteins: phospholipids in excess are the main precursors of lipoprotein-X-like particles. Biochim Biophys Acta. 1047:1990;121-130.
39. Rigaud D, Serog P, Legrand A, Cerf M, Appelbaum M, Bonfils A Quantification of lipoprotein X and its relationship to plasma lipid profile during different types of parenteral nutrition. J Parenteral Enteral Nutr. 8:1984;529-534.